Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
07 2021
Historique:
received: 05 10 2020
accepted: 26 03 2021
revised: 26 02 2021
pubmed: 9 5 2021
medline: 27 1 2022
entrez: 8 5 2021
Statut: ppublish

Résumé

Posttraumatic stress disorder (PTSD) is a debilitating syndrome with substantial morbidity and mortality that occurs in the aftermath of trauma. Symptoms of major depressive disorder (MDD) are also a frequent consequence of trauma exposure. Identifying novel risk markers in the immediate aftermath of trauma is a critical step for the identification of novel biological targets to understand mechanisms of pathophysiology and prevention, as well as the determination of patients most at risk who may benefit from immediate intervention. Our study utilizes a novel approach to computationally integrate blood-based transcriptomics, genomics, and interactomics to understand the development of risk vs. resilience in the months following trauma exposure. In a two-site longitudinal, observational prospective study, we assessed over 10,000 individuals and enrolled >700 subjects in the immediate aftermath of trauma (average 5.3 h post-trauma (range 0.5-12 h)) in the Grady Memorial Hospital (Atlanta) and Jackson Memorial Hospital (Miami) emergency departments. RNA expression data and 6-month follow-up data were available for 366 individuals, while genotype, transcriptome, and phenotype data were available for 297 patients. To maximize our power and understanding of genes and pathways that predict risk vs. resilience, we utilized a set-cover approach to capture fluctuations of gene expression of PTSD or depression-converting patients and non-converting trauma-exposed controls to find representative sets of disease-relevant dysregulated genes. We annotated such genes with their corresponding expression quantitative trait loci and applied a variant of a current flow algorithm to identify genes that potentially were causal for the observed dysregulation of disease genes involved in the development of depression and PTSD symptoms after trauma exposure. We obtained a final list of 11 driver causal genes related to MDD symptoms, 13 genes for PTSD symptoms, and 22 genes in PTSD and/or MDD. We observed that these individual or combined disorders shared ESR1, RUNX1, PPARA, and WWOX as driver causal genes, while other genes appeared to be causal driver in the PTSD only or MDD only cases. A number of these identified causal pathways have been previously implicated in the biology or genetics of PTSD and MDD, as well as in preclinical models of amygdala function and fear regulation. Our work provides a promising set of initial pathways that may underlie causal mechanisms in the development of PTSD or MDD in the aftermath of trauma.

Identifiants

pubmed: 33963278
doi: 10.1038/s41380-021-01084-3
pii: 10.1038/s41380-021-01084-3
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3077-3092

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH094757
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH094759
Pays : United States
Organisme : NICHD NIH HHS
ID : K12 HD085850
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Keane TM, Marx BP, Sloan DM. Post-traumatic stress disorder: definition, prevalence, and risk factors. In: LeDoux JE, Keane T, Shiromani P, editors. Post-traumatic stress disorder: basic science and clinical practice. Totowa, NJ: Humana Press; 2009, pp 1–19.
Rothbaum BO, Foa EB, Riggs DS, Murdock T, Walsh W. A prospective examination of post-traumatic stress disorder in rape victims. J Trauma Stress. 1992;5:455–75.
doi: 10.1002/jts.2490050309
Stein MB, Kennedy C. Major depressive and post-traumatic stress disorder comorbidity in female victims of intimate partner violence. J Affect Disord. 2001;66:133–8.
pubmed: 11578665 doi: 10.1016/S0165-0327(00)00301-3
Walter KH, Levine JA, Highfill-McRoy RM, Navarro M, Thomsen CJ. Prevalence of posttraumatic stress disorder and psychological comorbidities among U.S. Active Duty Service Members, 2006-2013. J Trauma Stress. 2018;31:837–44.
pubmed: 30398680 doi: 10.1002/jts.22337
Hoppen TH, Morina N. The prevalence of PTSD and major depression in the global population of adult war survivors: a meta-analytically informed estimate in absolute numbers. Eur J Psychotraumatol. 2019;10:1578637.
pubmed: 30834069 pmcid: 6394282 doi: 10.1080/20008198.2019.1578637
Muscatelli S, Spurr H, OʼHara NN, OʼHara LM, Sprague SA, Slobogean GP. Prevalence of depression and posttraumatic stress disorder after acute orthopaedic trauma: a systematic review and meta-analysis. J Orthop Trauma. 2017;31:47–55.
pubmed: 27997466 doi: 10.1097/BOT.0000000000000664
Ravi M, Stevens JS, Michopoulos V. Neuroendocrine pathways underlying risk and resilience to PTSD in women. Front Neuroendocrinol. 2019;55:100790.
pubmed: 31542288 pmcid: 6876844 doi: 10.1016/j.yfrne.2019.100790
Ramikie TS, Ressler KJ. Mechanisms of sex differences in fear and posttraumatic stress disorder. Biol Psychiatry. 2018;83:876–85.
pubmed: 29331353 doi: 10.1016/j.biopsych.2017.11.016
Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol. 2000;68:748–66.
pubmed: 11068961 doi: 10.1037/0022-006X.68.5.748
Tortella-Feliu M, Fullana MA, Pérez-Vigil A, Torres X, Chamorro J, Littarelli SA, et al. Risk factors for posttraumatic stress disorder: an umbrella review of systematic reviews and meta-analyses. Neurosci Biobehav Rev. 2019;107:154–65.
pubmed: 31520677 doi: 10.1016/j.neubiorev.2019.09.013
Sayed S, Iacoviello BM, Charney DS. Risk factors for the development of psychopathology following trauma. Curr Psychiatry Rep. 2015;17:612.
pubmed: 26206108
Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA. 2008;299:1291–305.
pubmed: 18349090 pmcid: 2441757 doi: 10.1001/jama.299.11.1291
McLaughlin KA, Koenen KC, Bromet EJ, Karam EG, Liu H, Petukhova M, et al. Childhood adversities and post-traumatic stress disorder: evidence for stress sensitisation in the World Mental Health Surveys. Br J Psychiatry. 2017;211:280–8.
pubmed: 28935660 pmcid: 5663970 doi: 10.1192/bjp.bp.116.197640
Keane TM, Marshall AD, Taft CT. Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Annu Rev Clin Psychol. 2006;2:161–97.
pubmed: 17716068 doi: 10.1146/annurev.clinpsy.2.022305.095305
Platt J, Keyes KM, Koenen KC. Size of the social network versus quality of social support: which is more protective against PTSD? Soc Psychiatry Psychiatr Epidemiol. 2014;49:1279–86.
pubmed: 24310782 doi: 10.1007/s00127-013-0798-4
Logue MW, van Rooij SJH, Dennis EL, Davis SL, Hayes JP, Stevens JS, et al. Smaller hippocampal volume in posttraumatic stress disorder: a multisite ENIGMA-PGC study: subcortical volumetry results from posttraumatic stress disorder consortia. Biol Psychiatry. 2018;83:244–53.
pubmed: 29217296 doi: 10.1016/j.biopsych.2017.09.006
Bremner JD, Vythilingam M, Vermetten E, Southwick SM, McGlashan T, Nazeer A, et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry. 2003;160:924–32.
pubmed: 12727697 doi: 10.1176/appi.ajp.160.5.924
Afifi TO, Asmundson GJ, Taylor S, Jang KL. The role of genes and environment on trauma exposure and posttraumatic stress disorder symptoms: a review of twin studies. Clin Psychol Rev. 2010;30:101–12.
pubmed: 19892451 doi: 10.1016/j.cpr.2009.10.002
Koenen KC, Hitsman B, Lyons MJ, Niaura R, McCaffery J, Goldberg J, et al. A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Arch Gen Psychiatry. 2005;62:1258–65.
pubmed: 16275813 doi: 10.1001/archpsyc.62.11.1258
Koenen KC, Lyons MJ, Goldberg J, Simpson J, Williams WM, Toomey R, et al. A high risk twin study of combat-related PTSD comorbidity. Twin Res. 2003;6:218–26.
pubmed: 12855071 doi: 10.1375/136905203765693870
Stein MB, Jang KL, Taylor S, Vernon PA, Livesley WJ. Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. Am J Psychiatry. 2002;159:1675–81.
pubmed: 12359672 doi: 10.1176/appi.ajp.159.10.1675
True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ, et al. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry. 1993;50:257–64.
pubmed: 8466386 doi: 10.1001/archpsyc.1993.01820160019002
Xian H, Chantarujikapong SI, Scherrer JF, Eisen SA, Lyons MJ, Goldberg J, et al. Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. Drug Alcohol Depend. 2000;61:95–102.
pubmed: 11064187 doi: 10.1016/S0376-8716(00)00127-7
Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571:489–99.
pubmed: 31341302 doi: 10.1038/s41586-019-1411-0
Dhaini HR, Daher Z. Genetic polymorphisms of PPAR genes and human cancers: evidence for gene-environment interactions. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2019;37:146–79.
pubmed: 31045458 doi: 10.1080/10590501.2019.1593011
Cust AE, Mishra K, Berwick M. Melanoma—role of the environment and genetics. Photochem Photobio Sci. 2018;17:1853–60.
doi: 10.1039/c7pp00411g
Chang X, Dorajoo R, Sun Y, Han Y, Wang L, Khor CC, et al. Gene-diet interaction effects on BMI levels in the Singapore Chinese population. Nutr J. 2018;17:31.
pubmed: 29477148 pmcid: 6389173 doi: 10.1186/s12937-018-0340-3
Kaul N, Ali S. Genes, genetics, and environment in type 2 diabetes: implication in personalized medicine. DNA Cell Biol. 2016;35:1–12.
pubmed: 26495765 doi: 10.1089/dna.2015.2883
Hawn SE, Sheerin CM, Lind MJ, Hicks TA, Marraccini ME, Bountress K, et al. GxE effects of FKBP5 and traumatic life events on PTSD: A meta-analysis. J Affect Disord. 2019;243:455–62.
pubmed: 30273884 doi: 10.1016/j.jad.2018.09.058
Smoller JW. The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology. 2016;41:297–319.
pubmed: 26321314 doi: 10.1038/npp.2015.266
Rabl U, Meyer BM, Diers K, Bartova L, Berger A, Mandorfer D, et al. Additive gene-environment effects on hippocampal structure in healthy humans. J Neurosci. 2014;34:9917–26.
pubmed: 25057194 pmcid: 4107408 doi: 10.1523/JNEUROSCI.3113-13.2014
Broadaway KA, Duncan R, Conneely KN, Almli LM, Bradley B, Ressler KJ, et al. Kernel approach for modeling interaction effects in genetic association studies of complex quantitative traits. Genet Epidemiol. 2015;39:366–75.
pubmed: 25885490 pmcid: 4469530 doi: 10.1002/gepi.21901
Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen CY, Choi KW, et al. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 2019;10:4558.
pubmed: 31594949 pmcid: 6783435 doi: 10.1038/s41467-019-12576-w
Gelernter J, Sun N, Polimanti R, Pietrzak R, Levey DF, Bryois J, et al. Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans. Nat Neurosci. 2019;22:1394–401.
pubmed: 31358989 pmcid: 6953633 doi: 10.1038/s41593-019-0447-7
Segman RH, Shefi N, Goltser-Dubner T, Friedman N, Kaminski N, Shalev AY. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry. 2005;10:500–13. 425
pubmed: 15685253 doi: 10.1038/sj.mp.4001636
Linnstaedt SD, Pan Y, Mauck MC, Sullivan J, Zhou CY, Jung L, et al. Evaluation of the association between genetic variants in circadian rhythm genes and posttraumatic stress symptoms identifies a potential functional allele in the transcription factor. Front Psychiatry. 2018;9:597.
pubmed: 30498461 pmcid: 6249322 doi: 10.3389/fpsyt.2018.00597
Myers AJ. The age of the “ome”: genome, transcriptome and proteome data set collection and analysis. Brain Res Bull. 2012;88:294–301.
pubmed: 22142972 doi: 10.1016/j.brainresbull.2011.11.015
Myers AJ. AD gene 3-D: moving past single layer genetic information to map novel loci involved in Alzheimer’s disease. J Alzheimer’s Dis. 2013;33:S15–22.
doi: 10.3233/JAD-2012-129013
Myers AJ. The genetics of gene expression multiple layers and multiple players. In: Coppola G, editor. The OMICs applications in neuroscience. New York, NY: Oxford University Press; 2014, pp 132–52.
Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L, et al. A survey of genetic human cortical gene expression. Nat Genet. 2007;39:1494–9.
pubmed: 17982457 doi: 10.1038/ng.2007.16
Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, et al. Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet. 2009;84:445–58.
pubmed: 19361613 pmcid: 2667989 doi: 10.1016/j.ajhg.2009.03.011
Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, et al. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain. 2020;141:2721–39.
Piehowski PD, Petyuk VA, Orton DJ, Xie F, Moore RJ, Ramirez-Restrepo M, et al. Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. J proteome Res. 2013;12:2128–37.
pubmed: 23495885 pmcid: 3695475 doi: 10.1021/pr301146m
Lebron-Milad K, Graham BM, Milad MR. Low estradiol levels: a vulnerability factor for the development of posttraumatic stress disorder. Biol Psychiatry. 2012;72:6–7.
pubmed: 22682395 doi: 10.1016/j.biopsych.2012.04.029
Milad MR, Zeidan MA, Contero A, Pitman RK, Klibanski A, Rauch SL, et al. The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience. 2010;168:652–8.
pubmed: 20412837 doi: 10.1016/j.neuroscience.2010.04.030
Maddox SA, Kilaru V, Shin J, Jovanovic T, Almli LM, Dias BG, et al. Estrogen-dependent association of HDAC4 with fear in female mice and women with PTSD. Mol Psychiatry. 2018;23:658–65.
pubmed: 28093566 doi: 10.1038/mp.2016.250
Elwood J, Murray E, Bell A, Sinclair M, Kernohan WG, Stockdale J. A systematic review investigating if genetic or epigenetic markers are associated with postnatal depression. J Affect Disord. 2019;253:51–62.
pubmed: 31029013 doi: 10.1016/j.jad.2019.04.059
Chikahisa S, Chida D, Shiuchi T, Harada S, Shimizu N, Otsuka A, et al. Enhancement of fear learning in PPARalpha knockout mice. Behav Brain Res. 2019;359:664–70.
pubmed: 30278189 doi: 10.1016/j.bbr.2018.09.020
Maguschak KA, Ressler KJ. Wnt signaling in amygdala-dependent learning and memory. J Neurosci. 2011;31:13057–67.
pubmed: 21917789 pmcid: 3184457 doi: 10.1523/JNEUROSCI.3248-11.2011
Kim YA, Przytycki JH, Wuchty S, Przytycka TM. Modeling information flow in biological networks. Phys Biol. 2011;8:035012.
pubmed: 21572171 pmcid: 3148109 doi: 10.1088/1478-3975/8/3/035012
Kim YA, Wuchty S, Przytycka TM. Identifying causal genes and dysregulated pathways in complex diseases. PLoS Comput Biol. 2011;7:e1001095.
pubmed: 21390271 pmcid: 3048384 doi: 10.1371/journal.pcbi.1001095
Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012;28:1353–8.
pubmed: 22492648 pmcid: 3348564 doi: 10.1093/bioinformatics/bts163
Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 2011;39:D685–90.
pubmed: 21071392 doi: 10.1093/nar/gkq1039
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289–300.
Wingo AP, Almli LM, Stevens JS, Stevens JJ, Klengel T, Uddin M, et al. DICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression. Nat Commun. 2015;6:10106.
pubmed: 26632874 doi: 10.1038/ncomms10106
Mercer KB, Dias B, Shafer D, Maddox SA, Mulle JG, Hu P, et al. Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1. Transl Psychiatry. 2016;6:e978.
pubmed: 27959335 pmcid: 5290337 doi: 10.1038/tp.2016.241
Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470:492–7.
pubmed: 21350482 pmcid: 3046811 doi: 10.1038/nature09856
Glover EM, Jovanovic T, Mercer KB, Kerley K, Bradley B, Ressler KJ, et al. Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. Biol Psychiatry. 2012;72:19–24.
pubmed: 22502987 pmcid: 3675159 doi: 10.1016/j.biopsych.2012.02.031
Graham BM, Milad MR. Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol Psychiatry. 2013;73:371–8.
pubmed: 23158459 doi: 10.1016/j.biopsych.2012.09.018
Cornil CA, Seredynski AL, de Bournonville C, Dickens MJ, Charlier TD, Ball GF, et al. Rapid control of reproductive behaviour by locally synthesised oestrogens: focus on aromatase. J Neuroendocrinol. 2013;25:1070–8.
pubmed: 23763492 doi: 10.1111/jne.12062
Gillespie CF, Almli LM, Smith AK, Bradley B, Kerley K, Crain DF, et al. Sex dependent influence of a functional polymorphism in steroid 5-alpha-reductase type 2 (SRD5A2) on post-traumatic stress symptoms. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:283–92.
pubmed: 23505265 doi: 10.1002/ajmg.b.32147
Fenchel D, Levkovitz Y, Vainer E, Kaplan Z, Zohar J, Cohen H. Beyond the HPA-axis: The role of the gonadal steroid hormone receptors in modulating stress-related responses in an animal model of PTSD. Eur Neuropsychopharmacol. 2015;25:944–57.
pubmed: 25771251 doi: 10.1016/j.euroneuro.2015.02.004
McEvoy K, Osborne LM, Nanavati J, Payne JL. Reproductive affective disorders: a review of the genetic evidence for premenstrual dysphoric disorder and postpartum depression. Curr Psychiatry Rep. 2017;19:94.
pubmed: 29082433 doi: 10.1007/s11920-017-0852-0
Gao L, Tober J, Gao P, Chen C, Tan K, Speck NA. RUNX1 and the endothelial origin of blood. Exp Hematol. 2018;68:2–9.
pubmed: 30391350 pmcid: 6494457 doi: 10.1016/j.exphem.2018.10.009
Scheitz CJ, Tumbar T. New insights into the role of Runx1 in epithelial stem cell biology and pathology. J Cell Biochem. 2013;114:985–93.
pubmed: 23150456 pmcid: 5788165 doi: 10.1002/jcb.24453
Wang JW, Stifani S. Roles of Runx genes in nervous system development. Adv Exp Med Biol. 2017;962:103–16.
pubmed: 28299654 doi: 10.1007/978-981-10-3233-2_8
Maguschak KA, Ressler KJ. Beta-catenin is required for memory consolidation. Nat Neurosci. 2008;11:1319–26.
pubmed: 18820693 pmcid: 2597638 doi: 10.1038/nn.2198
Dias BG, Goodman JV, Ahluwalia R, Easton AE, Andero R, Ressler KJ. Amygdala-dependent fear memory consolidation via miR-34a and Notch signaling. Neuron. 2014;83:906–18.
pubmed: 25123309 pmcid: 4172484 doi: 10.1016/j.neuron.2014.07.019
Hong F, Pan S, Guo Y, Xu P, Zhai Y. PPARs as nuclear receptors for nutrient and energy metabolism. Molecules. 2019;24:2545.
Bordet R, Ouk T, Petrault O, Gelé P, Gautier S, Laprais M, et al. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans. 2006;34:1341–6.
pubmed: 17073815 doi: 10.1042/BST0341341
Luo R, Su LY, Li G, Yang J, Liu Q, Yang LX, et al. Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy. 2020;16:52–69.
Patel D, Roy A, Kundu M, Jana M, Luan CH, Gonzalez FJ, et al. Aspirin binds to PPARα to stimulate hippocampal plasticity and protect memory. Proc Natl Acad Sci USA. 2018;115:E7408–17.
pubmed: 30012602 pmcid: 6077698 doi: 10.1073/pnas.1802021115
Roy A, Jana M, Kundu M, Corbett GT, Rangaswamy SB, Mishra RK, et al. HMG-CoA reductase inhibitors bind to PPARα to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab. 2015;22:253–65.
pubmed: 26118928 pmcid: 4526399 doi: 10.1016/j.cmet.2015.05.022
Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post‐traumatic stress disorder. J Trauma Stress. 1993;6:459–73.
doi: 10.1002/jts.2490060405
Foa EB, Tolin DF. Comparison of the PTSD symptom scale-interview version and the clinician-administered PTSD scale. J Trauma Stress. 2000;13:181–91.
pubmed: 10838669 doi: 10.1023/A:1007781909213
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
doi: 10.1001/archpsyc.1961.01710120031004 pubmed: 13688369
Foa EB, Rothbaum BA. Treating the trauma of rape: cognitive behavioral therapy for PTSD. New York, NY: Guilford Press; 1998.
Rothbaum BO, Kearns MC, Price M, Malcoun E, Davis M, Ressler KJ, et al. Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure. Biol Psychiatry. 2012;72:957–63.
pubmed: 22766415 pmcid: 3467345 doi: 10.1016/j.biopsych.2012.06.002
Rothbaum BO, Kearns MC, Reiser E, Davis JS, Kerley KA, Rothbaum AO, et al. Early intervention following trauma may mitigate genetic risk for PTSD in civilians: a pilot prospective emergency department study. J Clin Psychiatry. 2014;75:1380–7.
pubmed: 25188543 pmcid: 4293026 doi: 10.4088/JCP.13m08715
Kearns MC, Ressler KJ, Zatzick D, Rothbaum BO. Early interventions for PTSD: a review. Depress Anxiety. 2012;29:833–42.
pubmed: 22941845 pmcid: 3665083 doi: 10.1002/da.21997
Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, et al. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994;151:1132–6.
pubmed: 8037246 doi: 10.1176/ajp.151.8.1132
Michopoulos V, Beurel E, Gould F, Dhabhar FS, Schultebraucks K, Galatzer-Levy I, et al. Association of prospective risk for chronic PTSD symptoms with low TNFα and IFNγ concentrations in the immediate aftermath of trauma exposure. Am J Psychiatry. 2020;177:58–65.
Hinrichs R, van Rooij SJ, Michopoulos V, Schultebraucks K, Winters S, Maples-Keller J, et al. Increased skin conductance response in the immediate aftermath of trauma predicts PTSD risk. Chronic Stress. 2019;3:1–11.
Stevens JS, Kim YJ, Galatzer-Levy IR, Reddy R, Ely TD, Nemeroff CB, et al. Amygdala reactivity and anterior cingulate habituation predict posttraumatic stress disorder symptom maintenance after acute civilian trauma. Biol Psychiatry. 2017;81:1023–9.
pubmed: 28117048 doi: 10.1016/j.biopsych.2016.11.015
Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, et al. Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet. 2009;84:445–58.
pubmed: 19361613 pmcid: 2667989 doi: 10.1016/j.ajhg.2009.03.011
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
pubmed: 17701901 pmcid: 1950838 doi: 10.1086/519795
Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5:1564–73.
pubmed: 21085122 pmcid: 3025522 doi: 10.1038/nprot.2010.116
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–9.
pubmed: 16862161 doi: 10.1038/ng1847
Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods. 2011;9:179–81.
pubmed: 22138821 doi: 10.1038/nmeth.1785
Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529.
pubmed: 19543373 pmcid: 2689936 doi: 10.1371/journal.pgen.1000529
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
doi: 10.1038/nature15393
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
doi: 10.1093/bioinformatics/bts635 pubmed: 23104886
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinforma. 2016;17:483.
doi: 10.1186/s12859-016-1323-z
Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.
pubmed: 10592173 pmcid: 102409 doi: 10.1093/nar/28.1.27
Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2018;46:D649–55.
pubmed: 29145629 doi: 10.1093/nar/gkx1132
Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, et al. PID: the Pathway Interaction Database. Nucleic Acids Res. 2009;37:D674–9.
pubmed: 18832364 doi: 10.1093/nar/gkn653
Gandhi TK, Zhong J, Mathivanan S, Karthick L, Chandrika KN, Mohan SS, et al. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat Genet. 2006;38:285–93.
pubmed: 16501559 doi: 10.1038/ng1747
Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34:D535–9.
pubmed: 16381927 doi: 10.1093/nar/gkj109
Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res. 2003;31:248–50.
pubmed: 12519993 pmcid: 165503 doi: 10.1093/nar/gkg056
Bian Y, Yang L, Zhao M, Li Z, Xu Y, Zhou G, et al. Identification of key genes and pathways in post-traumatic stress disorder using microarray analysis. Front Psychol. 2019;10:302.
pubmed: 30873067 pmcid: 6403462 doi: 10.3389/fpsyg.2019.00302
Xu N, Zhou WJ, Wang Y, Huang SH, Li X, Chen ZY. Hippocampal Wnt3a is necessary and sufficient for contextual fear memory acquisition and consolidation. Cereb Cortex. 2015;25:4062–75.
pubmed: 24904070 doi: 10.1093/cercor/bhu121
Jiang P, Zhang WY, Li HD, Cai HL, Liu YP, Chen LY. Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats. Psychoneuroendocrinology. 2013;38:2091–8.
pubmed: 23608137 doi: 10.1016/j.psyneuen.2013.03.017
Ji LL, Tong L, Peng JB, Jin XH, Wei D, Xu BK, et al. Changes in the expression of the vitamin D receptor and LVSCC‑A1C in the rat hippocampus submitted to single prolonged stress. Mol Med Rep. 2014;9:1165–70.
pubmed: 24535566 doi: 10.3892/mmr.2014.1934
Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RG, van Heemst D. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging. 2009;30:466–73.
pubmed: 17714831 doi: 10.1016/j.neurobiolaging.2007.07.001
Kéri S, Szabó C, Kelemen O. Blood biomarkers of depression track clinical changes during cognitive-behavioral therapy. J Affect Disord. 2014;164:118–22.
pubmed: 24856564 doi: 10.1016/j.jad.2014.04.030
Muminovic Umihanic M, Babic R, Kravic N, Avdibegovic E, Dzubur Kulenovic A, Agani F, et al. Associations between polymorphisms in the solute carrier family 6 member 3 and the myelin basic protein gene and posttraumatic stress disorder. Psychiatr Danub. 2019;31:235–40.
pubmed: 31291231 doi: 10.24869/psyd.2019.235
Wang Q, Wang Z, Zhu P, Jiang J. Alterations of myelin basic protein and ultrastructure in the limbic system at the early stage of trauma-related stress disorder in dogs. J Trauma. 2004;56:604–10.
pubmed: 15128132 doi: 10.1097/01.TA.0000058122.57737.0E
Han Y, Sun CY, Meng SQ, Tabarak S, Yuan K, Cao L, et al. Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects. Mol Psychiatry. 2020;25:1260–74.
Lowe SR, Meyers JL, Galea S, Aiello AE, Uddin M, Wildman DE, et al. RORA and posttraumatic stress trajectories: main effects and interactions with childhood physical abuse history. Brain Behav. 2015;5:e00323.
pubmed: 25798337 pmcid: 4356849 doi: 10.1002/brb3.323
Miller MW, Wolf EJ, Logue MW, Baldwin CT. The retinoid-related orphan receptor alpha (RORA) gene and fear-related psychopathology. J Affect Disord. 2013;151:702–8.
pubmed: 24007783 pmcid: 3797180 doi: 10.1016/j.jad.2013.07.022
Amstadter AB, Sumner JA, Acierno R, Ruggiero KJ, Koenen KC, Kilpatrick DG, et al. Support for association of RORA variant and post traumatic stress symptoms in a population-based study of hurricane exposed adults. Mol Psychiatry. 2013;18:1148–9.
pubmed: 23319003 pmcid: 3977702 doi: 10.1038/mp.2012.189
Logue MW, Baldwin C, Guffanti G, Melista E, Wolf EJ, Reardon AF, et al. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry. 2013;18:937–42.
pubmed: 22869035 doi: 10.1038/mp.2012.113
Uddin M, Ratanatharathorn A, Armstrong D, Kuan PF, Aiello AE, Bromet EJ, et al. Epigenetic meta-analysis across three civilian cohorts identifies NRG1 and HGS as blood-based biomarkers for post-traumatic stress disorder. Epigenomics. 2018;10:1585–601.
pubmed: 30456986 pmcid: 6331697 doi: 10.2217/epi-2018-0049
Chen YH, Lan YJ, Zhang SR, Li WP, Luo ZY, Lin S, et al. ErbB4 signaling in the prelimbic cortex regulates fear expression. Transl Psychiatry. 2017;7:e1168.
pubmed: 28675393 pmcid: 5538119 doi: 10.1038/tp.2017.139
Lu Y, Sun XD, Hou FQ, Bi LL, Yin DM, Liu F, et al. Maintenance of GABAergic activity by neuregulin 1-ErbB4 in amygdala for fear memory. Neuron. 2014;84:835–46.
pubmed: 25451196 doi: 10.1016/j.neuron.2014.09.029
Taylor SB, Taylor AR, Koenig JI. The interaction of disrupted type II neuregulin 1 and chronic adolescent stress on adult anxiety- and fear-related behaviors. Neuroscience. 2013;249:31–42.
pubmed: 23022220 doi: 10.1016/j.neuroscience.2012.09.045
Kilaru V, Iyer SV, Almli LM, Stevens JS, Lori A, Jovanovic T, et al. Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder. Transl Psychiatry. 2016;6:e820.
pubmed: 27219346 pmcid: 5070067 doi: 10.1038/tp.2016.69
Pomytkin I, Costa-Nunes JP, Kasatkin V, Veniaminova E, Demchenko A, Lyundup A, et al. Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment. CNS Neurosci Ther. 2018;24:763–74.
pubmed: 29691988 pmcid: 6489906 doi: 10.1111/cns.12866
Bigio B, Mathé AA, Sousa VC, Zelli D, Svenningsson P, McEwen BS, et al. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance. Proc Natl Acad Sci USA. 2016;113:7906–11.
pubmed: 27354525 pmcid: 4948346 doi: 10.1073/pnas.1603111113
Sakharkar AJ, Zhang H, Tang L, Baxstrom K, Shi G, Moonat S, et al. Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol. 2014;17:1207–20.
pubmed: 24528596 doi: 10.1017/S1461145714000054
Lu HC, Tan Q, Rousseaux MW, Wang W, Kim JY, Richman R, et al. Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans. Nat Genet. 2017;49:527–36.
pubmed: 28288114 pmcid: 5374026 doi: 10.1038/ng.3808
Liu J, Su B. Integrated analysis supports ATXN1 as a schizophrenia risk gene. Schizophr Res. 2018;195:298–305.
pubmed: 29055568 doi: 10.1016/j.schres.2017.10.010

Auteurs

Stefan Wuchty (S)

Department of Computer Science, University of Miami, Coral Gables, FL, USA.
Department of Biology, University of Miami, Coral Gables, FL, USA.
Institute of Data Science and Computing, University of Miami, Coral Gables, FL, USA.
Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL, USA.

Amanda J Myers (AJ)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Interdepartmental Program in Neuroscience, University of Miami Miller School of Medicine, Miami, FL, USA.
Interdepartmental Program in Human Genetics and Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Center on Aging, University of Miami Miller School of Medicine, Miami, FL, USA.

Manuel Ramirez-Restrepo (M)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Matthew Huentelman (M)

Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.

Ryan Richolt (R)

Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.

Felicia Gould (F)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Philip D Harvey (PD)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Vasiliki Michopolous (V)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

Jennifer S Steven (JS)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

Aliza P Wingo (AP)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

Adriana Lori (A)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

Jessica L Maples-Keller (JL)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

Alex O Rothbaum (AO)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.
Department of Psychological Sciences, Case Western Reserve University, Cleveland, OH, USA.

Tanja Jovanovic (T)

Department of Psychiatry and Behavioral Sciences, Wayne State University, Detroit, MI, USA.

Barbara O Rothbaum (BO)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

Kerry J Ressler (KJ)

Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.
McLean Hospital, Harvard Medical School, Belmont, MA, USA.

Charles B Nemeroff (CB)

Department of Psychiatry, Dell School of Medicine, Univerity of Texas, Austin, TX, USA. cnemeroff@austin.utexas.edu.
Institute for Early Life Adversity Research, Dell School of Medicine, Univerity of Texas, Austin, TX, USA. cnemeroff@austin.utexas.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH